Could a common cholesterol drug help treat a rare liver disease?
NCT ID NCT06591455
First seen Jan 04, 2026 · Last updated May 14, 2026 · Updated 20 times
Summary
This early-phase study tested whether adding fenofibrate (a cholesterol-lowering drug) to standard treatment with ursodeoxycholic acid improves liver function in 30 adults newly diagnosed with primary biliary cholangitis (PBC), a chronic liver disease. The main goal was to see if the combination could normalize alkaline phosphatase levels, a key marker of liver damage. The study was small and exploratory, so results are preliminary and not yet conclusive.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY BILIARY CHOLANGITIS (PBC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Xijing hospital
Xi'an, Shaanxi, 710032, China
Conditions
Explore the condition pages connected to this study.